Información del artículo
El Texto completo está disponible en PDF
Biblografía
[1.]
F.X. Bosch, J. Ribes, J. Borras.
Epidemiology of primary liver cancer.
Semin Liver Dis, 19 (1999), pp. 271-285
[2.]
J. Bruix, M. Sherman, J.M. Llovet, M. Beaugrand, R. Lencioni, E. Christensen, et al.
Clinical management on hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL Conference.
J Hepatol, 35 (2001), pp. 421-430
[3.]
J.M. Llovet, C. Brú, J. Bruix.
Prognosis of hepatocellular carcinoma: The BCLC staging classification.
Semin Liver Dis, 19 (1999), pp. 329-338
[4.]
J.M. Llovet, J. Bruix, G. Gores.
Surgical resection vs transplantation for early hepatocellular carcinoma: Clues for the best strategy.
Hepatology, 31 (2000), pp. 1919-1921
[5.]
J. Fuster, J.C. García-Valdecasas, L. Grande, J. Tabet, J. Bruix, T. Anglada, et al.
Hepatocellular carcinoma and cirrhosis. Results of surgical treatment in a European series.
Ann Surg, 223 (1996), pp. 297-302
[6.]
A. Maziotti, G. Grazi, A. Cavallari.
Surgical treatment of hepatocellular carcinoma on cirrhosis: a western experience.
Hepatogastroenterology, 45 (1998), pp. 1281-1287
[7.]
J.M. Llovet, J. Fuster, J. Bruix.
for the BCLC Group. Intention to treat analysis for surgical treatment of hepatocellular carcinoma: resection vs transplantation.
Hepatology, 30 (1999), pp. 1434-1440
[8.]
S. Arii, Y. Yamaoka, S. Futagawa, K. Inoue, K. Kobayashi, M. Kojiro, et al.
Results of surgical and nonsurgical treatment for smallsized hepatocellular carcinomas: A retrospective and nationwide survey in Japan.
Hepatology, 32 (2000), pp. 1224-1229
[9.]
J. Yamamoto, S. Okada, K. Shimada, T. Okusaka, S. Yamasaki, H. Ueno, et al.
Treatment strategy for small hepatocellular carcinoma: Comparison of long-term results after percutaneous ethanol injection therapy and surgical resection.
Hepatology, 34 (2001), pp. 707-713
[11.]
J. Bruix, A. Castells, J. Bosch, F. Feu, J. Fuster, J.C. García-Pagan, et al.
Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure.
Gastroenterology, 111 (1996), pp. 1018-1022
[12.]
E. Mor, R.T. Kaspa, P. Sheiner, M. Schwartz.
Treatment of hepatocellular carcinoma associated with cirrhosis in the era of liver transplantation.
Ann Intern Med, 129 (1998), pp. 643-653
[13.]
C. Margarit, E. Hidalgo, R. Charco, D. Cura, L. Castells, E. Allende, et al.
Mejoría de los resultados de la resección quirúrgica del hepatocarcinoma.
Gastroenterol Hepatol, 24 (2001), pp. 465-472
[14.]
J. Bruix, J.M. Llovet.
Prognosis prediction and treatment strategy for hepatocellular carcinoma.
Hepatology, (2002),
[15.]
V. Mazzaferro, E. Regalia, R. Doci, S. Andreola, A. Pulvirenti, F. Bozzetti, et al.
Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis.
N Engl J Med, 334 (1996), pp. 693-699
[16.]
Y. Suárez, A. França, J.M. Llovet, J. Fuster, J. Bruix.
Advances in liver transplantation. The current status of liver transplantation for primary hepatic malignancy.
Clinics in Liver Disease, 4 (2000), pp. 591-605
[17.]
United Network for Organ Sharing.
Annual report, (1999),
[18.]
F. Sarasin, P. Majno, J.M. Llovet, J. Mentha, J. Bruix, A. Hadengue.
Liver donor liver transplantation for early hepatocellular carcinoma: a cost-effectiveness perspective.
Hepatology, 33 (2001), pp. 1073-1079
[19.]
J.M. Llovet, X. Mas, J. Aponte, J. Fuster, M. Navasa, E. Christensen, et al.
Cost-effectiveness of adjuvant therapy for hepatocellular carcinoma before liver transplantation.
Gut, 58 (2002),
[20.]
J.M. Llovet, R. Vilana, L. Bianchi, C. Brú.
Radiofrecuencia en el tratamiento del carcinoma hepatocelular. Progresos en Gastroenterología.
Gastroenterol y Hepatol, 34 (2001), pp. 303-311
Copyright © 2001. Elsevier España, S.L.. Todos los derechos reservados
